Skip to content

Modified SALT Score for Alopecia Areata

Modified SALT Score for Assessment of Alopecia Areata

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04412148
Enrollment
20
Registered
2020-06-02
Start date
2020-01-01
Completion date
2020-08-01
Last updated
2020-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alopecia Areata

Brief summary

Patchy Alopecia areata was treated by intralesional steroids for 3 months and was evaluated by percentage of involvement, mSALT score and dermoscopy.

Interventions

OTHERsaline

intralesional injection of saline

DRUGTriamcinolone Acetonide

intralesional injection of triamcinolone acetonide every 2 weeks for 6 sessions

Sponsors

Kasr El Aini Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* localized scalp AA ( 2 patches and ≤50% scalp involvement , duration more than 6 months) • patients who did not receive any medication for at least 2 months before starting the study and those who agreed to join the study and signed written consent.

Exclusion criteria

* • pregnant, and lactating females * Alopecia totalis or universalis or ophiasis or cicatritial alopecia * Usage of systemic treatment of alopecia areata 2 months prior to the study. * Any scalp lesion within the treated area * Bleeding diathesis, severe anemia or platelet disorders * Medical conditions such as autoimmune diseases.

Design outcomes

Primary

MeasureTime frameDescription
Percentage involvement6months to 1 yearDegree of severity expressed as a percentage
Modified Severity of Alopecia Tool (mSALT) score6 months to 1 yearNew Score calculating severity (hair density) and area as a number minimum value is 0 and maximum value is 105 the higher the number of the score the worse the affection

Countries

Egypt

Contacts

Primary ContactRana Hilal, MD
rana.hilal@kasralainy.edu.eg1001488869

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026